1.Raise awareness of targeting inflammation in DKD by Phosphodiesterases (PDEs).
2.Review the etiology of DKD.
3.Explore how PTX could be beneficial in patients unable to tolerate RAAS blockade.
01/09/2020 - 1:00pm to 2:00pm CST
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Dr. David Leehey